[Observation on Rhesus monkeys infected second time with H5N1 avian influenza virus]

Area of Science:

• Virology
• Immunology
• Infectious Diseases

Context:

• H5N1 avian influenza poses a significant public health threat.
• Understanding viral immunity and reinfection dynamics is crucial for vaccine development and pandemic preparedness.
• Previous studies have explored H5N1 immunity, but long-term protection and resistance to secondary infection require further investigation.

Purpose:

• To evaluate the outcome of a second H5N1 avian influenza A virus inoculation in Rhesus monkeys.
• To assess the impact of a primary H5N1 infection on the immune response and resistance to subsequent H5N1 challenge.
• To determine the duration of protective immunity following an initial H5N1 inoculation.

Summary:

• Rhesus monkeys received an initial intratracheal inoculation with H5N1 virus or a control. Three months later, they were challenged with H5N1 virus or a control. Monkeys with prior H5N1 exposure (NO. 3, 4, 5) exhibited high specific antibody levels and significantly reduced viral detection and lung pathology upon secondary challenge compared to the control group (NO. 6).
• Viral RNA (RT-PCR) and viral antigens (immunohistochemistry) were primarily detected in the lungs of the control monkey (NO. 6) with the most severe lung injury.
• Monkeys NO. 3, 4, and 5, which had recovered from the initial infection and retained high antibody titers, demonstrated enhanced resistance to the secondary H5N1 challenge.

Impact:

• This study demonstrates that Rhesus monkeys can develop robust and lasting immunity against H5N1 avian influenza A virus for at least 90 days.
• The findings highlight the potential for long-term protective immunity following H5N1 infection, suggesting implications for vaccine strategies.
• Enhanced resistance observed in previously infected monkeys provides valuable insights into host-pathogen dynamics and the development of effective countermeasures against highly pathogenic avian influenza.